Doxorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis

Polish Journal of Pharmacology

Volumn 50, Issue 2, 1998, Pages 151-157

  Muszyńska, Anna ^a   Pałka, Jerzy ^a   Wołczyński, Sławomir ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Collagen; Doxorubicin; Fibroblast; Prolidase

Indexed keywords

DOXORUBICIN; PROLINE DIPEPTIDASE;

ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN PROCESSING; SKIN FIBROBLAST; WOUND HEALING IMPAIRMENT;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DIPEPTIDASES; DOXORUBICIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; SKIN;

EID: 2642707518     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bland K. I., Palin W. E., Fraunhofer J. A., Morris R. R., Adcock R. A., Tobin G. R. II: Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann. Surg., 1984, 199, 782-790.
2. Burton K.: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 1956, 62, 315-323.
3. Calabresi P., Parks R. E., Jr.: Chemotherapy of neoplastic diseases. In: The Pharmacological Basis of Therapeutics. Eds. Gilman A. G., Goodman L. S., Gilman A., Macmillan Publishing Co., New York, 1980, 1249-1313.
4. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B.: Evaluation of a tetrazolinum-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 1987, 47, 936-42.
5. Casazza A. M.: Preclinical selection of new anthracyclines. Cancer Treat. Rep., 1986, 70, 43-49.
6. Chamson A., Voigtlander V., Myara I., Frey J.: Collagen biosynthetic anomalies in prolidase deficiency, effeet of glycyl-L-proline on the degradation of newly synthesized collagen. Clin. Physiol. Biochem., 1989, 7, 128-136.
7. Chinard F. P.: Photometric estimation of proline and ornithine. J. Biol. Chem., 1952, 199, 91-95.
8. Devereux D. F., Thibault L., Boretos J., Brennan M. F.. The quantitative and qualitative impairment of wound healing by adriamycin. Cancer (Phila.), 1979, 43, 932-938.
9. Devereux D. F., Triche T. J., Webber B. L., Thibault L. E., Brennan M. F.: A study of adriamycin-reduced wound breaking strength in rats. Cancer (Phila.), 1980, 45, 2811-2815.
10. Endo F., Tanoue A., Nakai H., Hata A., Indo Y., Titani K., Matsuda I.: Primary structure and gene localization of human prolidase. J. Biol. Chem., 1989, 264, 4476-4481.
11. Goodman S. I., Solomons C. C., Muschenheim F., Macintyre C. A., Miles B., O'Brien D.: A syndrome resembling lathyrism associated with iminodipeptiduria. Amer. J. Med., 1968, 45, 152-159.
12. Günzler V., Hanauske-Abel H. M., Myllylä R., Kaska D. D., Hanauske A., Kivirikko K. I.: Syncatalytic inactivation of prolyl 4-hydroxylase by anthracyclines. Biochem. J., 1988, 251, 365-372.
13. Jackson S.H., Dennis A. N., Greenberg M.: Iminopeptiduria. A genetic defect in recycling collagen: a method for determining prolidase in red blood cells. Can. Med. Assoc. J., 1975, 113, 759-763.
14. Kivirikko K. I., Myllylä R.: Post-translational processing of procollagens. Ann. NY Acad. Sci., 1985, 460, 187-201.
15. Laemmli U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227, 680-685.
16. Lowry O. H., Rosenbergh N. I., Farr A. L., Randall I. R.: Protein measurement with the Folin reagent. J. Biol. Chem., 1951, 265, 193.
17. Makela J. K., Vuorio T., Vuorio E.: Growth-dependent modulation of type I collagen production and mRNA levels in cultured human skin fibroblasts. Biochim. Biophys. Acta, 1990, 1049, 171-176.
18. Miltyk W., Karna E., Pałka J.: Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts. Pol. J. Pharmacol., 1996, 48, 609-613.
19. Myara I., Charpentier C., Gantier M., Lemonnier A.: A cell density affects prolidase and prolinase activity and intracellular amino acid levels in cultured human cells. Clin. Chim. Acta, 1985, 150, 1-9.
20. Myara I., Charpentier C., Lemonnier A.: Optimal conditions for prolidase assay by proline colorimetric determination: application to imidodipeptiduria. Clin. Chim. Acta, 1982, 125, 193-205.
21. 4 administration inducing liver cytolysis and fibrosis in rat. Brit. J. Exp. Pathol., 1987, 68, 7-13.
22. Oyamada I., Palka J., Schalk E. M., Takeda K., Peterkofsky B.: Scorbutic and fasted guinea pig sera contain an insulin-like growth factor-I reversible inhibitor of proteoglycan and collagen synthesis in chick embryo chondrocytes and adult human skin fibroblasts. Arch. Biochem. Biophys., 1990, 276, 85-93.
23. Pałka J.A., Karna E., Miltyk W.: Fibroblast chemotaxis and prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate. Mol. Cell. Biochem., 1997, 168, 177-183.
24. Pałka J., Miltyk W, Karna E., Wołczyński S.: Modulation of prolidase activity during in vitro aging of human skin fibroblasts the role of extracellular matrix collagen. Tokai J. Exp. Clin. Med., 1996, 21, 207-213.
25. Páka J. A., Phang J.: Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J. Cell. Biochem., 1997, 67, 166-175.
26. Peterkofsky B., Chojkier M., Bateman J.: Determination of collagen synthesis in tissue and cell culture system. In: Immunochemistry of the Extracellular Matrix. Eds. Furthmay M., CRC Press, Boca Raton, Fl, 1982, 19-47.
27. Phang J. M., Scriver C. R.: Disorders of proline and hydroxyproline metabolism. In: The Metabolic Basis of Inherited Diseases. Eds. Scriver C. R., Beaudet A. L., Sly W. S., Valle D., McGraw Hill, New York, 1989, 577-597.
28. Sasaki T, Holeyfield K. C., Vitto J.: Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. J. Clin. Invest., 1987, 80, 1735-1741.
29. Shamberger R.C., Devereux D. F., Brennan M. F.: The effect of chemotherapeutic agents on wound healing. Int. Adv. Surg. Oncol., 1981, 4, 15-58.
30. Yaron A., Naider F.: Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Molec. Biol., 1993, 28, 31-81.
31. Young R. C., Ozols R. F., Myers C. E.: Medical progress. The anthracycline antineoplastic drugs. N. Engl. J. Med., 1981, 305, 139-153.